According to the MHRA-approved SmPC, patients should discontinue tirzepatide if pancreatitis is suspected, and if confirmed, treatment should not be restarted
However, semaglutide has comprehensively surpassed exenatide in every clinical dimension: weight loss efficacy (approximately 4-5 fold greater), glycemic control (superior in SUSTAIN 3 head-to-head), cardiovascular outcomes (proven superiority vs non-inferiority), dosing convenience (pre-filled pen without reconstitution), and formulation options (oral available)
Regular check-ins and support help reinforce these changes for long-term success
Lipo 360 removes fat but does not remove skin, so it is enough only when your skin is still firm
And the strategy that separates lasting transformation from temporary weight loss comes down to understanding how two of the most powerful metabolic interventions in modern medicine actually interact at the cellular level